Denmark· DK-28105571915
Ghemaxan
A enoxaparin product containing enoxaparinnatrium, registered in Denmark by Chemi S.p.A.. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Enoxaparin is registered in 16 of 19 countries.
Countries holding a registration under ATC B01AB05 (enoxaparin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Enoxaparin · ATC B01AB05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- ENOXAPARINNATRIUM
- Manufacturer
- Chemi S.p.A.
- Country
- Denmark (DK)
- ATC code
- B01AB05
- ATC class
- Enoxaparin
- Defined daily dose
- 2 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105571915
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for enoxaparin.
Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Enoxaparin · interactions on record
203 records
- 106 severe
- 73 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B01AB05
Enoxaparin, as other registers publish it.
- United KingdomArovi 100mg/1ml solution for injection pre-filled syringesROVI Biotech Ltd
- United KingdomArovi 120mg/0.8ml solution for injection pre-filled syringesROVI Biotech Ltd
- United KingdomArovi 150mg/1ml solution for injection pre-filled syringesROVI Biotech Ltd
- United KingdomArovi 20mg/0.2ml solution for injection pre-filled syringesROVI Biotech Ltd
- United KingdomArovi 40mg/0.4ml solution for injection pre-filled syringesROVI Biotech Ltd
- United KingdomArovi 60mg/0.6ml solution for injection pre-filled syringesROVI Biotech Ltd
- United KingdomArovi 80mg/0.8ml solution for injection pre-filled syringesROVI Biotech Ltd
- CanadaAXBERIBAXTER CORPORATION
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c7eec8bc-0c25-40e9-bec7-348c83d9b9ce GET /v1/drugs/c7eec8bc-0c25-40e9-bec7-348c83d9b9ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning i fyldt injektionssprøjte",
"source": "dkma",
"strength": "150 mg",
"auth_role": "CMS",
"dk_drugid": "28105571915",
"substance": "ENOXAPARINNATRIUM",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "43221"
}See everything about enoxaparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.